U.S. Physical Therapy, Inc. (NYSE:USPH) Expected to Announce Quarterly Sales of $121.47 Million

Wall Street brokerages expect U.S. Physical Therapy, Inc. (NYSE:USPH) to report sales of $121.47 million for the current quarter, Zacks Investment Research reports. Three analysts have provided estimates for U.S. Physical Therapy’s earnings, with the lowest sales estimate coming in at $119.00 million and the highest estimate coming in at $124.67 million. U.S. Physical Therapy posted sales of $113.12 million during the same quarter last year, which would indicate a positive year over year growth rate of 7.4%. The company is scheduled to announce its next quarterly earnings results before the market opens on Thursday, November 7th.

On average, analysts expect that U.S. Physical Therapy will report full-year sales of $489.73 million for the current fiscal year, with estimates ranging from $484.00 million to $496.99 million. For the next financial year, analysts anticipate that the firm will report sales of $521.19 million, with estimates ranging from $509.70 million to $539.77 million. Zacks’ sales calculations are a mean average based on a survey of research firms that that provide coverage for U.S. Physical Therapy.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Thursday, August 8th. The company reported $0.81 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.81. U.S. Physical Therapy had a return on equity of 19.19% and a net margin of 6.22%. The business had revenue of $126.40 million during the quarter, compared to analysts’ expectations of $124.86 million. During the same period in the previous year, the firm posted $0.73 earnings per share. The company’s revenue was up 9.8% on a year-over-year basis.

Several research firms recently commented on USPH. ValuEngine cut U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Zacks Investment Research reissued a “buy” rating and set a $145.00 target price on shares of U.S. Physical Therapy in a research note on Saturday, October 5th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. U.S. Physical Therapy has an average rating of “Hold” and a consensus price target of $119.54.

Shares of NYSE USPH traded up $2.33 during trading on Friday, reaching $131.90. The stock had a trading volume of 529 shares, compared to its average volume of 83,426. U.S. Physical Therapy has a fifty-two week low of $98.69 and a fifty-two week high of $138.58. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.88 and a current ratio of 1.88. The business’s 50-day moving average price is $132.03 and its 200-day moving average price is $122.17. The company has a market cap of $1.64 billion, a P/E ratio of 49.67, a PEG ratio of 3.57 and a beta of 1.12.

In other news, COO Graham D. Reeve sold 952 shares of the business’s stock in a transaction dated Monday, August 12th. The stock was sold at an average price of $134.00, for a total value of $127,568.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Christopher J. Reading sold 601 shares of the business’s stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $135.39, for a total value of $81,369.39. The disclosure for this sale can be found here. Insiders sold a total of 22,803 shares of company stock valued at $3,067,830 over the last three months. Company insiders own 2.50% of the company’s stock.

A number of institutional investors and hedge funds have recently bought and sold shares of USPH. TCG Advisors LP purchased a new stake in U.S. Physical Therapy during the 1st quarter valued at approximately $25,000. NumerixS Investment Technologies Inc purchased a new stake in U.S. Physical Therapy during the 2nd quarter valued at approximately $61,000. Ladenburg Thalmann Financial Services Inc. raised its stake in U.S. Physical Therapy by 74.0% during the 2nd quarter. Ladenburg Thalmann Financial Services Inc. now owns 548 shares of the company’s stock valued at $67,000 after acquiring an additional 233 shares during the last quarter. Tower Research Capital LLC TRC purchased a new position in shares of U.S. Physical Therapy during the 2nd quarter worth approximately $91,000. Finally, Resources Investment Advisors LLC. raised its stake in shares of U.S. Physical Therapy by 96.6% during the 2nd quarter. Resources Investment Advisors LLC. now owns 816 shares of the company’s stock worth $100,000 after buying an additional 401 shares in the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Further Reading: What is the Fibonacci sequence?

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.